Serina Therapeutics, Inc. (SER)

NYSEAMERICAN: SER · Real-Time Price · USD

5.39

-0.11 (-2.00%)

Aug 15, 2025, 9:35 AM - Market open

Serina Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	55	47	-	-	-
Enterprise Value	51	55	-	-	-
Last Close Price	5.50	5.01	-	-	-
PS Ratio	433.68	840.25	-	-	-
PB Ratio	34.25	92.63	-	-	-
P/TBV Ratio	-	73.41	-	-	-
EV/Sales Ratio	389.99	990.71	-	-	-
Debt / Equity Ratio	0.22	0.91	0.90	-0.77	1.19
Asset Turnover	0.01	0.01	0.64	0.44	-
Quick Ratio	1.70	1.55	5.39	1.22	3.53
Current Ratio	2.24	2.40	5.39	1.25	3.58
Return on Equity (ROE)	-	-485.36%	594.25%	-	-
Return on Assets (ROA)	-132.37%	-124.04%	-19.46%	-105.01%	-
Return on Capital (ROIC)	-	-221.85%	-26.28%	-1390.61%	-
Earnings Yield	-22.54%	-23.68%	-	-	-
FCF Yield	-27.81%	-36.47%	-	-	-
Buyback Yield / Dilution	-138.29%	-0.11%	-242.70%	-0.01%	-

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q